1. Home
  2. MNPR vs SJT Comparison

MNPR vs SJT Comparison

Compare MNPR & SJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNPR
  • SJT
  • Stock Information
  • Founded
  • MNPR 2014
  • SJT 1980
  • Country
  • MNPR United States
  • SJT United States
  • Employees
  • MNPR N/A
  • SJT N/A
  • Industry
  • MNPR Biotechnology: Pharmaceutical Preparations
  • SJT Oil & Gas Production
  • Sector
  • MNPR Health Care
  • SJT Energy
  • Exchange
  • MNPR Nasdaq
  • SJT Nasdaq
  • Market Cap
  • MNPR 248.8M
  • SJT 269.4M
  • IPO Year
  • MNPR 2019
  • SJT N/A
  • Fundamental
  • Price
  • MNPR $44.21
  • SJT $5.78
  • Analyst Decision
  • MNPR Strong Buy
  • SJT
  • Analyst Count
  • MNPR 10
  • SJT 0
  • Target Price
  • MNPR $66.56
  • SJT N/A
  • AVG Volume (30 Days)
  • MNPR 38.8K
  • SJT 233.5K
  • Earning Date
  • MNPR 11-07-2025
  • SJT 08-13-2025
  • Dividend Yield
  • MNPR N/A
  • SJT N/A
  • EPS Growth
  • MNPR N/A
  • SJT N/A
  • EPS
  • MNPR N/A
  • SJT N/A
  • Revenue
  • MNPR N/A
  • SJT $42,635.00
  • Revenue This Year
  • MNPR N/A
  • SJT N/A
  • Revenue Next Year
  • MNPR N/A
  • SJT N/A
  • P/E Ratio
  • MNPR N/A
  • SJT N/A
  • Revenue Growth
  • MNPR N/A
  • SJT N/A
  • 52 Week Low
  • MNPR $2.29
  • SJT $3.22
  • 52 Week High
  • MNPR $54.30
  • SJT $7.22
  • Technical
  • Relative Strength Index (RSI)
  • MNPR 65.29
  • SJT 47.87
  • Support Level
  • MNPR $32.77
  • SJT $5.69
  • Resistance Level
  • MNPR $36.49
  • SJT $5.85
  • Average True Range (ATR)
  • MNPR 2.93
  • SJT 0.16
  • MACD
  • MNPR 1.14
  • SJT 0.01
  • Stochastic Oscillator
  • MNPR 99.97
  • SJT 48.98

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

About SJT San Juan Basin Royalty Trust

San Juan Basin Royalty Trust is an energy sector royalty trust in the United States. It owns approximately 75% net profit interest in a large number of natural gas properties in the San Juan Basin of New Mexico. About 98% of the royalties San Juan collects come from natural gas, with the balance coming from oil.

Share on Social Networks: